0 Members and 1 Guest are viewing this topic.
Scientists at Duke University have developed an antibody that targets cancer cells and triggers an immune response to kill tumors while leaving other cells unharmed. The emerging approach to cancer treatment holds promise as an alternative to existing immunotherapies that pose unwanted side effects, researchers said.